Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Nasopharyngeal Carcinoma or Children
and you are
under 18
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

1. To see the effect if a combination of induction chemotherapy followed by chemoradiotherapy works in treating children with advanced nasopharyngeal carcinoma(NPC).

Provided treatments

  • Drug: Paclitaxel liposome
  • Drug: Cisplatin
  • Drug: 5-fu
  • Radiation: Radical radiotherapy
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03020329. The sponsor of the trial is Sun Yat-sen University and it is looking for 37 volunteers for the current phase.
Official trial title:
Phase II Study of TPF Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Young Patients With Locoregionally Advanced Nasopharyngeal Carcinoma